Intravenous Administration of an Oncolytic Vesicular Stomatitis Virus: Clinical Experience to Date
Time: 9:00 am
day: Day Two
Details:
- Voyager V1 has been administered intravenously to over 100 cancer patients in clinical trials
- Compelling evidence of single agent activity after a single infusion will be presented
